Minimal Residual Disease is a Prognostic Marker for Neuroblastoma With Bone Marrow Infiltration

Matthay, 2009, Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a Childrens Oncology Group Study., J Clin Oncol, 27, 1007, 10.1200/JCO.2007.13.8925

Park, 2009, Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the childrens oncology group., Pediatr Blood Cancer, 52, 44, 10.1002/pbc.21784

Pearson, 2008, High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial., Lancet Oncol, 9, 247, 10.1016/S1470-2045(08)70069-X

Modak, 2010, Neuroblastoma: therapeutic strategies for a clinical enigma., Cancer Treat Rev, 36, 307, 10.1016/j.ctrv.2010.02.006

Pession, 2003, Real-time RT-PCR of tyrosine hydroxylase to detect bone marrow involvement in advanced neuroblastoma., Oncol Rep, 10, 357

Cheung, 2004, Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis., Cancer, 101, 2303, 10.1002/cncr.20660

Mehes, 2001, Combined automatic immunological and molecular cytogenetic analysis allows exact identification and quantification of tumor cells in the bone marrow., Clin Cancer Res, 7, 1969

Jiao-Yang, 2007, Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34 selection in childhood advanced neuroblastoma., Pediatr Blood Cancer, 49, 952, 10.1002/pbc.21253

Warzynski, 2002, Flow cytometric immunophenotyping test for stagingmonitoring neuroblastoma patients., Cytometry, 50, 298, 10.1002/cyto.10159

Beiskea, 2005, Detecting minimal residual disease in neuroblastoma patients: the present state of the art., Cancer Lett, 228, 229, 10.1016/j.canlet.2005.02.053

Nagai, 2000, A new sensitive and specific combination of CD81CD56CD45 monoclonal antibodies for detecting circulating neuroblastoma cells in peripheral blood using flow cytometry., J Pediatr Hematol Oncol, 22, 20, 10.1097/00043426-200001000-00004

Tsang, 2003, Detection of micrometastasis of neuroblastoma to bone marrow and tumor dissemination to hematopoietic autografts using flow cytometry and reverse transcriptase-polymerase chain reaction., Cancer, 97, 2887, 10.1002/cncr.11389

Seeger, 2000, Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Childrens Cancer Group Study., J Clin Oncol, 18, 4067, 10.1200/JCO.2000.18.24.4067